Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
concentrated growth factor + bone substitute
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Concentrated Growth Factor
1 trial -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
diet management strategy for encephalopathy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatic Encephalopathy
1 trial -
etomidate anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthesia
1 trial -
folic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Neural Tube Defects - Spina Bifida and Anencephaly
1 trial -
hAECs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Premature Ovarian Failure
1 trial -
high protein
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Life Quality
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Learning Disabilities
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
7 trials -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
lidocaine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
2 trials -
mitomycin C
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obstructive Airway Disease
1 trial -
multi-intervention program and protein foods supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcopenia
1 trial -
n-3 Polyunsaturated fatty acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
nutrition treat
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Crohn's Disease
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
only antiemetic (Ramosetron, Tropisetron and dexamethasone)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemotherapy-induced Nausea and Vomiting
1 trial -
oxygen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Interoception
1 trial -
oxytocin treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial -
placebo (compared to vasoconstrictor)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Adult Male
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources